Authors: Zhu Zhengfei et al. Fudan University Shanghai Cancer Center Translated by: Kong Yuehong Reviewed by: Zhang...
prag.app
Source of Research Article: Cao C, Wang L, Jiang F, et al. Granulocyte-macrophage colony-stimulating factor for newly...
A new multicenter Phase II clinical trial, led by researchers from several institutions including Jiangsu Cancer Hospital,...
An Innovative Hope for Pancreatic Cancer: A Case Study of PRaG 3.0 Therapy Pancreatic cancer is one...
Introduction: A New Hope for Metastatic Gastric Cancer Gastric cancer (GC) is one of the most common...
Introduction to Thyroid Hürthle Cell Carcinoma and Its Challenges Thyroid cancer is the most common type of...
Metastatic triple-negative breast cancer (mTNBC) presents a formidable challenge due to its aggressive nature and poor prognosis....
Cancer treatment is a field where no two journeys are the same. The case of advanced malignant...
Introduction: The Ongoing Struggle Against Metastatic Colon Cancer As I read through the case of a metastatic...
Introduction: The Challenge of Platinum-Resistant Ovarian CancerOvarian cancer, particularly in its platinum-resistant form, remains one of the...
Introduction: A New Hope for Refractory Metastatic ESCCEsophageal squamous cell carcinoma (ESCC) is a highly aggressive cancer...
Introduction: A Breakthrough in Metastatic Gastric Cancer TreatmentGastric cancer, particularly when metastatic, often presents with a poor...
Introduction: Overcoming Resistance in Cancer TreatmentCancer therapy has come a long way in recent years, with immunotherapies,...
If you are someone who follows developments in cancer treatment, especially in the realm of immunotherapy and...
PRaG therapy is an innovative cancer treatment regimen that based on radiotherapy, PD-1/PD-L1 inhibitors, and granulocyte-macrophage colony-stimulating...